o2h ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Monument Therapeutics
25 Feb 2025
Monument Therapeutics secures £850k led by ACF Investors to advance schizophrenia treatment with MT1988
Monument Therapeutics applies digital biomarkers to psychiatric drug development, advancing combination therapies designed to improve cognitive impairment in schizophrenia alongside existing antipsychotic treatments.
Atelerix
28 Jan 2025
Atelerix lands £750k from ACF Investors and o2h ventures to revolutionise biological transport
Atelerix develops hydrogel technology that allows biological samples to be stored and shipped at ambient temperatures while maintaining cell viability.
o2h ventures
More venture news
- 25 Jun 2026
HR DuoHR Duo secures £1.4m in funding led by Puma Growth Partners to build workforce management platform for frontline-heavy SMEs
EquityHR - 23 Jun 2026
LabCycleLabCycle raises £180k from British Design Fund to scale circular recycling system for contaminated laboratory plastics
EquityClimate - 19 Jan 2026
LabCycleLabCycle unlocks funding from Angel Academe to solve the circular recycling of laboratory plastic waste
EquityClimate
